Skip to main content

Full text of "USPTO Patents Application 09864891"

See other formats


PCX 



WORLD INTELLECTUAL PROPERTY ORGANIZATION 
international Bureau 



INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) 



(51) International Patent Classification ^ : 

G06F 19/00, 159/00 



Al 



(11) International Publication Number: 



WO 97/41525 



(43) International Publication Date: 6 November 1997 (06.11. 97) 



(21) International Application Number: PCT/AU97/00250 

(22) International Filing Dale: 24 April 1997 (24.04.97) 



(30) Priority Data: 
PN 9521 



26 April 1996 (26.04.%) 



AU 



(71) Applicant (for alt designated States except US): HUNTER 

AREA PATHOLOGY SERVICE [AU/AUl; Lookout Road. 
New Lambton HcighLs. NSW 2035 (AU). 

(72) Inventors; and 

(75) inventors/Applicants (for US only): ENNO. Amo [AU/AU]; 
80 Church Street. Newcastle. NSW 2300 (AU). COX, 
Craig (AU/AUl: 29 Pottlcwell Road. Fern Bay, NSW 2295 
(AU). W<X)DFORD. Phillip lAU/AU); 16 The Anchorage. 
Dudley. NSW 2290 (AU). 

(74) Agent: GRIFFITH HACK; G.P.O. Box 4164. Sydney. NSW 
2001 (AU). 



(81) Designated States: AL. AM. AT. AU. AZ. BA. BE. BG. BR. 
BY, CA. CH. CN. CU. CZ. DE, DK. EE, ES. FI. GB. GE. 
GH. HU. IL. IS, JP. KE KG. KP. KR. K2. LC. LK. LR. 
LS. LT. LU. LV, MD. MG. MK. MN. MW, MX. NO. NZ. 
PL, PT. RO. RU. SD. SE. SG. SI, SK. TJ, TM. TR, TT. 
UA. UG. US, UZ. VN, YU. ARIPO patent (GH, KE, LS. 
MW. SD, SZ. UG), Eurasian patent (AM. AZ. BY. KG. KZ. 
MD, RU. TJ. TM), European patent (AT. BE. CH. DE. DK. 
ES. R. FR, GB. GR, IE. IT. LU. MC. NL. PT. SE). OAPI 
patent (BF, BJ, CF. CG. CI, CM. GA. GN. ML. MR, NE. 
SN. TD, TG). 



Published 

With international search report. 



(54) Title: BLOOD PROCESSING SYSTEM 



(57) Abstract 

A computer system for controlling the dispens- 
ing of blood to a patient comprising a ^rst data entry 
means for entering first patient record details including 
blood group and antibody screening details for the pa- 
tient; second data entry means for entering second pa- 
tient record details for the patient the computer system 
cross-checking the second patient record details against 
portions of the first patient record details the computer 
system detemriining a group of compatible blood packs 
for the patient from available blood stocks; third data en- 
try means for entering details of a proposed compatible 
blood pack from the available blood stocks; and autho- 
risation output means outputting an authorisation when 
the proposed compatible blood pack is one of the group 
of compatible blood packs as detennined by the com- 
puter system. A computer system as claimed in claim 
1 wherein the first data entry means is remote from the 
second data entry means. 



TRANdFUdiON rearm 



SAMPLE 



resr^FLE 
rooeTE/^hnNE 



STORE OETAILS 
OF RS5ULT3 

FOR ^\MFtE 



■AdEDfCAL RECOUP mJM^$^ 
■HOSFfTAL 

mtE 

'dmiPATE 
ess 





FfWESS Perots 




/N dEWurs 




RE6fSrER 




'LA&mm^ 




'NAME 




-GSS ^ 




ESTABU5H 




E3R5 m$i 




RECORP 



- 3rof4PArs 



FOR THE PURPOSES OF INFORMATION ONLY 



Codes used to identify Stales party to the PCT on the from 



AL 


Albajiia 


ES 


Spain 


AM 


Armenia 


FI 


Finland 


AT 


Austria 


PR 


Fiince 


KM 


Australia' 


GA 


Gabon 


AZ 


Aztrbaijin 


GB 


Usiied Kingdom 


BA 


Bosnia and Herzegovina 


GE 


Oeorsia 


BB 


Barbados 


Gil 


China 


BE 


Belgium 


GN 


Gatnea 


BP 


Burkina Faso 


GR 


Greece 


BG 


Bulfaria 


IIU 


Hungary 


BJ 


Benin 


IE 


Ireland 


BR 


Brazil 


IL 


Tsnel 


BY 


Belanis 


IS 


Iceland 


CA 


Canada 


IT 


haly 


CP 


Central African RepubUc 


JP 


Japan 


CC 


Congo 


KE 


Kenya 


CH 


Swiizerlind 


KG 


Kyrgyistan 


CI 


COte d* I voire 


KP 


Democniic People 'i 


CM 


Cameroon 




Republic of Korea 


CN 


Chira 


KR 


Republic of Korea 


CU 


CutM 


KZ 


Kazakstan 


CZ 


Cztch Republic 


LC 


Sami Lucia 


DR 


Ccnnany 


U 


Liechieostetn 


DK 


Denmark 


LK 


Sri Larka 


RE 


Estonia 


LR 


Ubcria 



pages of pamphlets publishing international applications under the PCT. 



LS 


i.esotho 


SI 


Slovenia 


LT 


Lithuania 


SK 


Slovakia 


LU 


Luxembourg 


SN 


Senegal 


LV 


Latvia 


sz 


Swaziland 


MC 


Monaco 


TO 


Chad 


MD 


Republic of Moldova 


TG 


Togo 


MG 


Madagascar 


TJ 


Tajikittan 


MK 


The former Yugoslav 


TM 


Turkmenistan 




Republic of Macedonia 


TR 


Turkey 


ML 


Mali 


TT 


Trinidad and Toba^ 


MN 


Mongolia 


UA 


Ukraine 


MR 


Mauritania 


UG 


Uganda 


MW 


Malawi 


US 


United Sutes of America 


MX 


Mexico 


uz 


Uzbekistan 


NE 


Niger 


VN 


Vie* Nam 


NL 


Nethertands 


YU 


Yugoslavia 


NO 


Norway 


ZW 


Zimbabwe 


NZ 


New Zealand 






PL 


Poland 






PT 


Ponupt 






RO 


Romania 






RU 


Russian Federatioa 






SD 


Sudan 







SE Sweden 
SG Singipore 



wo 97/41525 



PCT/AU97/00250 



BlcxDd Processing System 

Field of the Invention 

The present invention relates to the identification, 
storage and dispensing of blood and blood products to 
5 patients requiring blood transfusions. 
Background of the Invention 

In hospital procedures, it is often necessary for a 
patient to receive a blood transfusion as part of an 
operation or the like. The need to ensure that a patient 

10 receives a compatible type blood is of great importance, 
with the consequence of receiving incompatible blood 
including possible fatality. 

For a full discussion of likely blood transfusion 
errors which can occur in practice, reference is made to 

15 "A Report of 104 Transfusion Errors in New York State" by 
J V Linden, B Paul, and K P Dressier, published in 
Transfusion, Volume 32, No. 7, pages 601-606. This 
journal article reports that error rates for blood 
transfusions can occur in modern societies at 

20 approximately the rate of 1 error per 12,000 transfusions. 

It has been further found in practice that doctors, 
not wishing to be caught short in their blood supply, 
often choose to over order blood supply stocks so that 
blood is always on hand in case of emergencies, especially 

25 in casualty wards. This has lead to high levels of 
wastage or spoilage in that excessive supply is required 
to satisfy demands which may not be realised and depend 
substantially on chance. 

Further, with prior art blood dispensing systems, 

30 excessive amounts of clerical processing are normally 
required in addition to high levels of skill required in 
dealing with blood and knowing what blood types and tests 
must be carried out before blood can be made available for 
transfusion . 



SUBSTITUTE SHEET (Rule 26) 



'^0 9V4XS1S PCr/AU97/00250 

Summary of the Invention 

. It is an object of the present invention to provide 
an improved method for handling blood which is amenable to 
a reduction in the likelihood of transfusion errors and to 
allow for a system which results in a reduction in our 
blood wastage due to the leviation of storage requirements 
and also provides for an automated system allowing for 
persons with lower levels of professional training to 
handle blood and its dispensing. 

In accordance with an aspect of the present invention 
there, is provided a computer system for controlling the 
dispensing of blood to a patient comprising: 

first data entry means for entering first patient 
record details including blood group and antibody 
screening details for said patient; 

second data entry means for entering second patient 
record details for said patients- 
said computer system cross-checking said second 
patient record details against portions of said first 
patient record 'details; 

said computer system determining a set of compatible 
blood packs for said patient from available blood stocks; 

third data entry means for entering details of a 
proposed compatible blood pack from said available blood 
stocks; and 

authorisation output means outputting an 
authorisation when said proposed compatible blood pack is 
one of said set of compatible blood packs as determined by 
said computer system. 

Preferably the blood group and antibody screening 
details can be obtained from testing a sample of the 
patient's blood and entering them in the first data entry 
means. 

Further, the authorisation can comprise printing out 
adhesive labels for the blood pack and, in an extra step 
the full details of the blood pack may be re-entered into 



SUBSTITUTE SHEET (Rule 26) 



wo 97/41525 PCT/AU97/00250 

- 3- 

the computer system at a later stage, for example, before 
dispensing . 

Of course, the system can be comprised from multiple 
computers interconnected in a predetermined manner by 
5 means of a network or the like. 

Both the test results of the patient and the blood 
products themselves can be time stamped and the computer 
system can take this into account in refusing to issue any 
authorisations when certain predetermined time periods 
10 have expired. Further, a patient's history can be "built 
up" and each tiine transfusion is to occur, this history 
can be examined to check for any anomalies. 

The system of the preferred embodiment has the 
significant advantage that blood release is completely 
15 controlled by a computer system. Hence, the preferred 
embodiment does not need to rely on intervention by 
laboratory staff during the blood release to ensure pre- 
transfusion requirements are met. 

In the preferred embodiment, the computer system 
20 performs all the checking functions and subsequently 
matches and selects the compatible pack{s) of blood from 
an inventory. This allows the preferred embodiment to 
operate away from the laboratory environment and to be 
used by non-laboratory hospital staff at remote hospitals 
25 interconnected into the computer system of the preferred 
embodiment . 

Brief Description of the Drawings 

Notwithstanding any other forms which may fall within 
the scope of the present invention, preferred forms of the 
30 invention will now be described, by way of example only, 
with reference to the accompanying drawings in which: 

Fig, 1 illustrates the process of a first embodiment 
in testing a blood transfusion sample; and 

Figs 2 illustrates a flow-chart for determining 
35 whether transfusion blood should be released by the first 
embodiment . 



SUBSTITUTE SHEET (Rule 26) 



wo 97/41525 

PCT/AU97/D0250 

- 4- 

Fig. 3 illustrates the interaction of computer 
. systems when utilised by a user to dispense blood; and 

Fig. 4 illustrates a flow chart for establishing a 
EBRS record; and 

Fig. 5 illustrates a flow chart for the release of 
blood in accordance with the second embodiment. 
Description of the Preferred and Other Embodiments 

In the preferred embodiment, reliance is placed on 
the integration of parts of the blood transfusion process 
within a computer system to extensively monitor the 
process to detect possible errors. 

It is assumed that the preferred embodiment is to run 
in an environment in which donated blood for transfusion 
has been analysed and categorised by blood group and 
antibody screening with the details being stored on a 
blood bank computer system and the details of which can be 
accessed by the preferred embodiment. Further, blood 
stocks have been delivered to hospital in accordance with 
expected needs and the level of stocks has been recorded. 

The method of the preferred embodiment can be divided 
into two main parts, the first part comprises the testing 
of a patient's blood to determine its blood group and 
antibody screening properties. The second part comprises 
determining blood which should be released to the patient 
when transfusion blood is needed. 

Referring to Fig. 1, there is illustrated the steps 
involved in the transfusion testing part of the preferred 
embodiment . 

In a first step 2 a blood sample, taken from a 
patient, is received along with the patient details. The 
patient details include the patient's name, birth date, 
hospital from which the blood is received, and a unique 
medical record number (MRN) for the patient to which 
uniquely identifies the patient. The sample is tested 3 
at the receiving pathology laboratory to determine the 



SUBSTITUTE SHEET (Rule 26) 



wo 97/41525 



PCT/AU97/00250 



- 5- 



sample's blood group (G) in addition to performing an 
antibody screening of the blood (S) . 

The results of the testing process are first entered 
4 into the computer system of the main pathology 
5 laboratory. These results are entered without any checks 
being performed against previous results. Details entered 
include a lab identification number, a patent's medical 
record number (MRN) , the hospital, name, patient birth 
date and the blood group and antibody screening results. 
10 Secondly, the details are entered in a separate register 6 
which is separate from the storage of details 4. In the 
register 6, the sample's lab number and the patient's name 
are utilised to identify the sample. 



15 information stored in step 4. A further register is 
maintained of all patient's antibody details. Each time a 
patient's sample is entered, the antibody register is 
firstly checked to see if a discrepancy exists and 
secondly the patient's antibody details are updated. If a 

20 discrepancy exists, the process terminates with a relevant 
notification to the user. 

Next, the patient's blood group results are again 
entered at step 6. The entry must be a valid blood group 
code and the entered blood group code is then validated 

25 against all samples previously received for the same 
patient which had been previously stored in the main 
laboratory computer system 4 or have been stored in the 
patient antibody register. Again, any inconsistencies 
result in termination of the method 1 with an appropriate 

30 notice. 

The antibody screening results S are then entered 6 
and checked against all previous records 4 for the same 
patient in addition to the patient antibody register. Any 
results that indicate an antibody has been detected, again 
35 results in program termination with an appropriate 



After entry, this information is compared against the 



message . 




PCT/AU97AKtt50 

- 6- 

If no inconsistencies are found, an Electronic Blood 
. Release System (EBRS) record is created 7 which has a time 
out value of between either 3 to 14 days over which it 
will remain valid, with the validity period being 
determined depending on the transfusion history of the 
patient, including the patient's blood group and antibody 
screening results. This record is then stored on the main 
laboratory system for access at a later date. 

Referring now to Figs. 2 and 3 there will now be 
explained the preferred method of releasing blood at a 
remote station, such as a hospital or the like. To this 
end, it is assumed that the hospital's computer system is 
connected to the main laboratory computer system and able 
to exchange information therewith. 

In Fig. 3, there is illustrated one possible 
arrangement of computers of the preferred embodiment. In 
this arrangement, a user's computer 30, within a hospital 
environment is interconnected to the aforementioned main 
laboratory computer system 31, the hospital's computer 
system 32 and the blood bank's computer system 33 which 
contains records of blood donors and blood types. 

Referring to Fig. 2, access to the transfusion blood 
release system begins by utilising a password 21 to access 
the system running on computer system 30 (Fig. 3). 
Preferably, a high level of security is provided by 
allowing for multiple passwords before access is achieved. 
Next, the computer informs the user to enter the required 
patient's full name, hospital identifier and the date of 
birth. This data entry is validated by checking for the 
corresponding EBRS record (7 of fig. 1) located on the 
main laboratory computer system 31 (Fig. 3), as well as 
checking the stored details of the results sample 4 and 
cross-checking against the information which may be 
available on the hospital's master patient index located 
on the hospital computer system 33 (Fig. 3). Thirdly, the 
blood bank computer system records 33 are searched to 



SUBSTITUTE SHEET (Rule 26) 



wo 97/41525 PCT/AU97/00250 

- 7- 

ensure that no antibodies exist for the person needing the 
transfusion. If there are any abnormalities or errors, 
the transfusion blood release system 20 is designed to 
terminate after reporting any error. 
5 As noted previously, the EBRS record is examined to 

determine if the record is still valid. If a valid record 
is found, a list of compatible blood pack numbers are 
determined 24 from those blood packs which are available 
at the remote site. It is assumed that the blood packs 

10 have been pretested and categorised as is the normal 
procedure for handling donated blood. The user is 
instructed to choose one of the compatible blood packs. 
Importantly, the system only displays blood packs that are 
in date, and have a blood group as previously verified by 

15 the 'dispensing blood laboratory. 

Next, the user is instructed to enter a donation 
number previously printed on the selected blood pack in 
addition to the blood group barcodes on the selected pack. 
For convenience and accuracy, the information" can be 

20 entered by means of bar codes or the like. This 
information is then checked to determine if it is correct 
and a matching label is printed. 

After affixing the label to the blood pack 26, the 
user is instructed to rescan all the blood pack package 

25 details. The system again checks that the blood pack is 
ABO compatible with the EBRS record of the patient. Upon 
confirmation, a release label 28 is printed for attachment 
to the patient's notes as a record of the blood 
transfusion release and the blood is available for us. 

30 Additionally, the laboratory computer system is 

updated to reflect the blood presently available at the 
local hospital system. This information can be utilised 
by the laboratory computer system producing warnings when 
stocks are running below minimum level and to advise on 
- 35 the necessity for further deliveries. 



SUBSmUTE SHEET (Rule 26) 



wo 97/41525 PCT/AU97/00250 

- 8- 

Turning now to Fig. 4 and Fig. 5, there will now be 

. described a further, slightly modified embodiment of the 
present invention . 

In this embodiment ABO and Rh(D) typing 40 of 
patients is performed using anti-A, anti-B and anti-D 
reagents. Serum typing is performed with Al and B cells 
against a 2 drop serum tube test. The antibody screening 
test is performed by a standard tube technique consisting 
of a ten minute, direct agglutination test at 37**C and a 
Low ionic strength solution indirect antiglobulin test 
(LISS-IAT) against a three cell sample screening panel. 

A second technologist independently 41 determines the 
patients blood type and enters the patient information and 
blood type result into the computer. The program 
validates the current and any historical data. Any 
discrepancies are flagged for resolution. The program 
creates a valid EBRS patient record 42 if i) a second 
blood type has been performed ii) current and historical 
44 patient identification and blood type tesults match 46 
and iii) there is no current or historical record of 
unexpected red cell antibodies 45. A full lAT crossmatch 
is performed for patients with red cell antibodies and an 
ISX is performed when no second technologist . is 
immediately available to perform a check of the ABO and 
Rh(D) type. The EBRS patient record expires after 72 
hours if the patient has been transfused within 3 months 
or is pregnant, otherwise a 14 day expiry applies. 

In Fig. 5, there is illustrated 50 the process of 
releasing blood in accordance with the second embodiment. 

Access to the EBRS programs requires dual passwords 
51. The computer informs the user to enter 52 the 
patient's full name, unique hospital number and date of 
birth. This entry is validated by the laboratory 
information system, the EBRS database and the Hospital 
patient information database. For a remote-site user, the 
programs searches 53 for a valid blood type and the 



SUBSmure sheet (RuIc 26) 



wo 97/41525 PCT/AU97/00250 

- 9- 

resuits of the antibody screen. If the antibody screen is 
negative a list of compatible RBC unit numbers available 
at the remote site is displayed 5^. The user is 
instructed to scan the donor unit identifying number and 
5 blood type barcodes of the selected unit and if valid, a 
label is printed. After fixing the label to the unit, the 
user is instructed to confirm 55 the unit selection by 
again scanning the unit details. If confirmed, a second 
label is printed for completion by the medical staff at 

10 the time of transfusion for inclusion in the patient's 
medical record. Immediate electronic mail messages are 
sent to the central laboratory indicating the release 
details and to warn the central laboratory when stocks are 
falling below minimum levels. 

15 By utilising the aforementioned procedures, the 

likelihood of blood transfusion errors is substantially 
reduced, thereby resulting in a safer blood processing 
system. 

Further, when utilising a system in accordance with 
20 the preferred embodiment it was found that there was a 
significant reduction in the volume of units requested by 
medical staff. This is thought due to the case and speed 
with which compatible blood can be dispensed as a result 
of removal of the need for a serological cross match. 
25 Further, the availability of ^computer cross matched red 
blood cell units in emergency situations enhances patient 
safety. 

It would be appreciated by a person skilled in the 
art that numerous variations and/or modifications may be 
30 made to the present invention as shown in the specific 
embodiment without departing from the spirit or scope of 
the invention as broadly described. The present 

embodiment is, therefore, ' to be considered in all respects 
to be illustrative and not restrictive. 



SUBSTTTUTC SHEET (Rule 2fi) 



10 



15 



"^0 91^525 PCr/AU97/00250 

- 10- 

CLAIMS : 

1. A computer system for controlling the dispensing 
of blood to a patient comprising: 

first data entry means for entering first patient 
record details including blood group and antibody 
screening details for said patient; 

second data entry means for entering second patient 
record details for said patient; 

said computer system cross-checking said second 
patient record details against portions of said first 
patient record details; 

said computer ^ system determining a group of 
compatible blood packs for said patient from available 
blood stocks; 

third data entry means for entering details of a 
proposed compatible blood pack from said available blood 
stocks ; and 

authorisation output means outputting an 
authorisation when said proposed compatible blood pack is 
one of said group of compatible blood packs as determined 
by said computer system. 

- 2. A computer system as claimed in claim 1 wherein 
said first data entry means is remote from said second 
data entry means. 

25 3. A computer system as claimed in any preceding 

claims wherein said blood group and antibody screening 

details are obtained from testing a sample of said 
patient's blood. 

4. A computer system as claimed in any preceding 
claim wherein said computer system further comprises a 
network of interlinked computers. 

5. A computer system as claimed in any preceding 
claim wherein said authorisation includes an adhesive 
label for placing on said proposed compatible blood pack. 

^5 ^- A computer system as claimed in any preceding 

claim wherein portions of said patient record details are 

SUBSTITUTE SHEET (RULE 26) 



20 



30 



wo 97/41525 PCT/AU97/00250 

- n- 

entered twice and stored in two separate storage locations 
and cross-referenced to one another. 

I. A computer system as claimed in any preceding 
claim wherein said first patient record details are time 

5 stamped and said computer system refuses to issue an 
authorisation when the elapsed time from said time stamp 
exceeds a predetermined timeout interval. 

8. A computer system as claimed in any preceding 
claim wherein, said computer system further requires 

10 reentry of said authorisation details. 

9. A computer system as claimed in any preceding 
claim wherein said cross-checking also includes checking 
said second patient record details against previously 
entered first patient record details. 

15 10. A computer system as claimed in any preceding 

claim wherein said cross-checking also includes checking 
said second patient record details against available 
hospital record details for said patient. 

II. A computer system as claimed in any preceding 
20 claim wherein said blood packs have associated timestamps 

and said group of compatible blood packs includes only 
those blood packs having timestamps less than a 
predetermined interval from a current time whose 
timestamps are greater then a predetermined time passed. 
25 12. A system for dispensing blood substantially as 

hereinbefore described with reference to the accompanying 
drawings. 



SUBSmTTEE SHEET (Rule 26) 



wo 97/41S2S 



PCT/AU97y002$0 



1/5 



TRANdFUdlON TE&TING 




TESTdAMPLt 
TO DETERMINE 
BIDOP GROUP (G) 
/WPANTWPr 
dCREEHINO (&) 




5T0RE PETA/LS 
OF RESULTS 
FOR SAMPLE 




LAd NUMBER 

MEDICAL RECORD NUMBER (MRN) 

HOSPITAL 

NAME 

3IRTHDATE 

6SS 



PROCESS PETALS 
IN SEPARATE 
REGISTER 



LA5 NUMBER 
NAME 

G^3 ,7 



ESTABLISH 
EBRS (GSS) 
RECORD 



- 3 TO 14 PAYS 



Fie. i 



SUBSTTTUTE SHEET (Rule 2fi) 



wo 97/41525 



PCT/AU97/00250 



2/5 



TRANdFUO/ON BLOOP /^ELfAdE 



UTILIZE PAdSWOf^P ACCESS 



El 



ENTER PAT/EN NAME, 
mSE/TAL AMP PATE OFmTH 



EXIT 



a3 



1 



VALIPATE A6AIN6T: 
(1) EBRS /^ECOf^P 
(E) LABOEATORY EAT/ENT F/LE 
id)H05PlTAL FAT/ENT MASTER INDEX 



EXIT 



PETEFMINE COMFAVBLE BlDOP 
GROUP A dCREENiNG 



i 



QCAN DONATDN NUMBER 3UX>P 
^ GROUP BARCODES d PRINT LABEL 



^^^SX/T 




EXIT 



Fie. £ 



SUBSnrUIE sheet (Ru1« 26) 



wo 97/41525 



PCT/AU97/00250 



r 



MAN 



COMPUTER 

SYSTEM 
(PATIENT FILE:) 



i 



LA5 



3/5 



r 



HOSP/TAL 
COMPUTER 

SYSTEM 
(PATIENT PILE) 



i 



3f 



i 



HOSPITAL UdEJ^d 



3Z 



r 



33 

1 



BLOOD mNK 
COMPUTE/^ 
SYdTEM 
(PATIENT FILE) 




i 



LA5 
U&EJ^ 



FIG. 3 



suBsnnrrE sheet (Me 26) 



PCT/AU97/00250 



4/5 



dAMPLE 



40 



1 



TYPING 
RE/HEATED 



41 




ENrEREXnPt 
OF SAMPLE 



EBR5 PEOO/^D 



Fie. 4 



SUBSTITUTE SHEET (Rule 26) 



wo 97/41525 



PCT/AU97/W)250 



5/5 



/^ASSiVO/^P OF 



i 



PATIENT 
JPENT/F/CAVON 



5f 



5Z 



50 



YES 





UNlTd XMATCHED 
dYLABOmORY^ 



YES 



U SEP XMATCHED 
UA//T5 



A/0 



P/3ELAYE3f^ 

C OMEAT/BLE UNTTS 

i 



OOS/EIEM 
dELECT/ON 



i 



UNTTS EELEAdEP 



54- 



EMAIL TO 
LASOmORY 



Fie. 5 



SUBSTTTUTE SHEET (Rule 26) 



INTERNATIONAL SEARCH REPORT 


Imemaiionai Application No. 




PCT/AU 97/00250 


A. CLASSIFICATION OF SUBJECT MATTER 


ImCl^- G06F 19/00. 159/00 




Accordini; lo International Patent Classificauon (IPC) or to both national classification and IPC 


B. FIELDS SEARCHED 


Minimum documcnUtion searched (classification system followed by classification symbols) 




IPC: G06F 19/00, 159/00 




G06F 15/42 




[)ocumentation searched other than minimum documentation to the extent that such documents arc included in the fields searched 


AU: IPC as above 





Electronic data base consulted during the international search (name of daU base and, where practicable, search terms used) 



PAIS 



C. 



DOCUME^^^s considered to be relevant 



Category* 



Citation of document, with indication, where appropriate, of the relevant passages 



Relevant to claim No 



AU.B, 70390/96 (677942) (DISKINESIS DEVELOPMENTS PTY LTD) 8 May 
1997 



WO.A, 91/06917 (GARCIA) 16 May 1991 



1 j FuTther documents tre listed in the contimulioo of Ek>x C 




1 y 1 See patent family aimex 


* Special categories of cited documents: 

*A" document defming the general state of the art which is 
not considered to be of particular relevance 

H" earlier document but polished on or after the 
intemational filirtg date 

"L" document which may throw doubts on priority claim(s) 
or which is cited to establish the publication date of 
another citation or other special reason (as specified) 

"O" document, referring to an oral disclosure, use. 
exhibition or other means 

"P" document published prior lo the intemational filing 
dale but later than the priority date claimed 


T" later document published after the international filing date or 
priority date and not in conflict with the application but cited to 
understand the principle or theory urulerlying the invention 

"X" document of particular relevance; the claimed invention carmot 
be coitsidered novel or cannot be considered to involve an 
inventive step when the document is taken alone 

"Y" document of particular relevance; the claimed invention cannot 
be considered to involve an inventive step when the document is 
combined with one or more other such documents, such 
combination being obvious to a person skilled in the an 
document member of the same patent family 


Date of Oic actual completion of the intemational search 
20 June 1997 


Dale of mailing of the international search report 

03 JUL 1997 


Name and mailing address of the ISA/AU 

AUSTRALIAN INDUSTRIAL PROPERTY ORGANISATION 

PO BOX 200 
WODEN ACT 2606 

AUSTRALIA Facsinulc No. : (06) 285 3929 


Authorized officer 

M. EMAMI 

Telephone No.: (06) 283 2204 



Form PCT/ISA/2 10 (second sheet) (July 1992) copjhw 



INTERNATIONAL SEARCH REPORT Intcmauonal Apphcauon No 

Information on patent family members pct/au 97/00250 

This Annex lists the known A" publication level patent family members relating to the patent documents cited 
in the above-mentioned international search repon. The Australian Patent Office is in no way liable for these 
particulars which are merely given for the purpose of information. 



Patent Document Cited in Search 
Repon 






Patent Family Member 






WO 9106917 


AU 
US 


66220/90 
5065315 


CA 2067747 


EP 


497832 



Form PCT/1SA/2I0 (extra sheet) (July 1992) copjhw 



END OF ANNEX